These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10231774)

  • 1. [Incorporation of the test of resistance to antiretroviral drugs in clinical practice].
    Soriano V; Briones C
    Med Clin (Barc); 1999 Mar; 112(11):412-5. PubMed ID: 10231774
    [No Abstract]   [Full Text] [Related]  

  • 2. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.
    Mascolini M; Wensing AM; Boucher CA
    IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306
    [No Abstract]   [Full Text] [Related]  

  • 3. Putting resistance to the test.
    Daar ES
    Posit Living; 2001 Apr; 10(3):15-6, 43-6. PubMed ID: 11548369
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV drug resistance testing: an update for the clinician.
    Rice HL; Zolopa AR
    AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resistance to antiretroviral drugs].
    Tamalet C; Yahi N; Koch N
    Med Trop (Mars); 1997; 57(2):121-6. PubMed ID: 9304001
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tests to detect resistance to antiretroviral agents in clinical practice].
    Seriano Vázquez V; Rodríguez-Rosado y Martínez-Echevarría R; Martínez-Echevarría
    Rev Clin Esp; 1999 Mar; 199(3):179-83. PubMed ID: 10230303
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 8. [GESIDA Consensus document on the use of resistance studies in clinical practice].
    Gatell JM; Blanco JL; Alcamí J; Antela A; Arrizabalaga J; Casado JL; Clotet B; Delgado R; Erice A; Guerra L; Guerrero A; Iribarren JA; Leal M; López JC; Menéndez-Arias L; Miró JM; Moreno S; Pérez JL; Pumarola T; Rubio R; Ruiz L; Santamaría JM; Soriano V; Telenti A; Viciana P
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):53-60. PubMed ID: 11428062
    [No Abstract]   [Full Text] [Related]  

  • 9. Salvage therapy for patients failing their current antiretroviral regimen.
    Albrecht MA
    AIDS Clin Rev; 2000-2001; ():139-91. PubMed ID: 10999220
    [No Abstract]   [Full Text] [Related]  

  • 10. [Resistance investigations during HIV-therapy is necessary].
    Schattenfroh S
    Dtsch Med Wochenschr; 1998 Feb; 123(7):A7. PubMed ID: 9505940
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-1 drug resistance assays in clinical management.
    Martinez-Picado J; D'Aquila R
    AIDS Clin Care; 1998 Nov; 10(11):81-5, 87-8. PubMed ID: 11365861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV drug resistance testing: data be damned.
    Res Initiat Treat Action; 2000 Dec; 6(4):25-7. PubMed ID: 11708172
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in the virology of HIV infections and implications for clinical management.
    Vella S
    AIDS Clin Care; 1998 Mar; 10(3):17-9. PubMed ID: 11365117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical HIV-1 isolates remain sensitive to stavudine following prolonged therapy.
    Deminie CA; Bechtold CM; Riccardi K; Rose RE; Samanta H; Lin PF; Colonno RJ
    AIDS; 1998 Jan; 12(1):110-2. PubMed ID: 9456262
    [No Abstract]   [Full Text] [Related]  

  • 15. [HIV susceptibility determination: a qualified position against regarding a complex technology].
    Telenti A
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):45-6. PubMed ID: 11428060
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV suppression and risk of drug resistance mutations.
    Phillips AN; Loveday C; Johnson MA
    AIDS; 1998 Oct; 12(14):1930. PubMed ID: 9792396
    [No Abstract]   [Full Text] [Related]  

  • 17. [Human immunodeficiency virus and antiretroviral therapy resistance].
    Quirós E; Torti C; Carosi G
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):234-7. PubMed ID: 10974768
    [No Abstract]   [Full Text] [Related]  

  • 18. Your next nightmare: 28% of new HIV cases may be drug-resistant.
    AIDS Alert; 1999 Dec; 14(12):133-7. PubMed ID: 11366987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral drug resistance mutations in antiretroviral-naive prisoners.
    Stone DR; Corcoran C; Wurcel A; McGovern B; Quirk J; Brewer A; Sutton L; D'Aquila RT
    Clin Infect Dis; 2002 Oct; 35(7):883-6. PubMed ID: 12228827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viro diversity (or, keeping up with HIV's evolutionary caprice).
    Mascolini M
    IAPAC Mon; 2001 Jul; 7(7):198-207. PubMed ID: 11785465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.